Elm Street Ventures
Seed and early-stage venture fund based in New Haven, CT, that primarily invests in companies with technology connections to Yale University. The firm focuses on translating university research into companies across therapeutics, advanced materials, green chemistry and climate-related technologies, and provides early capital, co-founding support, and ongoing portfolio guidance.
Industries
biotechnology
financial-services
venture-capital-b37d
Nr. of Employees
small (1-50)
Elm Street Ventures
Expertise Areas
- Early-stage venture investing
- University-to-market technology transfer
- Biotechnology and therapeutics commercialization
- Materials commercialization and pilot manufacturing
Key Technologies
- Protein degradation therapeutics
- Receptor-targeted small-molecule therapeutics (e.g., mGluR5 antagonists)
- Targeted protein-based cancer mechanisms (RIPTAC-style modalities)
- Tumor microenvironment-targeted delivery (low-pH targeting)